Biotherapy of Brain Tumors with Phosphatidylserine-Targeted Radioiodinated SapC-DOPS Nanovesicles.
Davis, HW; Vallabhapurapu, SD; Chu, Z; Wyder, MA; Greis, KD; Fannin, V; Sun, Y; Desai, PB; Pak, KY; Gray, BD; et al.
Cells.
2020;
9:1960-1960.
Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
Sun, Y; Liou, B; Chu, Z; Fannin, V; Blackwood, R; Peng, Y; Grabowski, GA; Davis, HW; Qi, X.
EBioMedicine.
2020;
55:102735-102735.
Lead Optimization of Benzoxazolone Carboxamides as Orally Bioavailable and CNS Penetrant Acid Ceramidase Inhibitors.
Di Martino, S; Tardia, P; Cilibrasi, V; Caputo, S; Mazzonna, M; Russo, D; Penna, I; Realini, N; Margaroli, N; Migliore, M; et al.
Journal of Medicinal Chemistry.
2020;
63:3634-3664.
Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease.
Schiffer, V; Santiago-Mujika, E; Flunkert, S; Schmidt, S; Farcher, M; Loeffler, T; Schilcher, I; Posch, M; Neddens, J; Sun, Y; et al.
PLoS ONE.
2020;
15:e0227077-e0227077.
Combination of acid beta-glucosidase mutation and Saposin C deficiency in mice reveals Gba1 mutation dependent and tissue-specific disease phenotype.
Liou, B; Zhang, W; Fannin, V; Quinn, B; Ran, H; Xu, K; Setchell, KD R; Witte, D; Grabowski, GA; Sun, Y.
Scientific Reports.
2019;
9.
Intravenous infusion of iPSC-derived neural precursor cells increases acid β-glucosidase function in the brain and lessens the neuronopathic phenotype in a mouse model of Gaucher disease.
Peng, Y; Liou, B; Inskeep, V; Blackwood, R; Mayhew, CN; Grabowski, GA; Sun, Y.
Human Molecular Genetics.
2019;
28:3406-3421.
Progranulin deficiency leads to reduced glucocerebrosidase activity.
Zhou, X; Paushter, DH; Pagan, MD; Kim, D; Santos, MN; Lieberman, RL; Overkleeft, HS; Sun, Y; Smolka, MB; Hu, F.
PLoS ONE.
2019;
14:e0212382-e0212382.
Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease.
Chen, Y; Jian, J; Hettinghouse, A; Zhao, X; Setchell, KD R; Sun, Y; Liu, C.
Journal of Molecular Medicine.
2018;
96:1359-1373.
Chitinase-3-like Protein 1: A Progranulin Downstream Molecule and Potential Biomarker for Gaucher Disease.
Jian, J; Chen, Y; Liberti, R; Fu, W; Hu, W; Saunders-Pullman, R; Pastores, GM; Chen, Y; Sun, Y; Grabowski, GA; et al.
EBioMedicine.
2018;
28:251-260.
The effect of manganese exposure in Atp13a2-deficient mice.
Fleming, SM; Santiago, NA; Mullin, EJ; Pamphile, S; Karkare, S; Lemkuhl, A; Ekhator, OR; Linn, SC; Holden, JG; Aga, DS; et al.
NeuroToxicology.
2018;
64:256-266.